Clinical Trials in North Carolina

Showing 18361-18380 of 20,428 trials

Drug Eluting Stent Registry of Thrombosis

NCT00812552

Multicenter, case-control study, to collect data regarding incidences of late and very late drug-eluting stent thrombosis with the aim of identifying trends and possible correlates of stent thrombosis.

Coronary Artery Disease

Medstar Health Research Institute984 participantsStarted Sep 2009

Sacramento, California, United States • Washington D.C., District of Columbia, United States • Springfield, Illinois, United States +17 more locations

COMPLETEDPhase 241 miles

Treatment of Moderate to Severe Facial Acne Vulgaris

NCT00612573

Randomized, multi-center, double-blind, placebo-controlled 12-week study to assess the safety and efficacy of 3 doses of an oral formulation of Doxycycline oral tablets using the Investigator's Global Assessment (IGA) score and the absolute change from baseline in inflammatory lesion count in patients with moderate to severe facial acne vulgaris. Additionally, the absolute change from baseline in non-inflammatory and total lesions of the active study medication to placebo will be evaluated.

Acne Vulgaris

Warner Chilcott257 participantsStarted Feb 2008

Encino, California, United States • Fremont, California, United States • Los Angeles, California, United States +20 more locations

Drug Eluting Stent Registry of Thrombosis

Treatment of Moderate to Severe Facial Acne Vulgaris

Find Trials by Condition in North Carolina

A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents

THE IMPROVE TRIAL: Improving Pain Management and Outcomes With Various Strategies of Patient-Controlled Analgesia (PCA)

Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer

Studying Cerebrospinal Fluid Proteins and Angiogenesis Proteins in Young Patients With Newly Diagnosed Central Nervous System Tumors

Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes

S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis

A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen

Phased Treatment for Social Anxiety Disorder and Coping Behaviors in a Medical Setting

The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART

Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART

Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson Disease

Pilot Study of Minocycline in Huntington's Disease

A Study of E7389 in Advanced/Metastatic Breast Cancer Patients

Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)

A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer

Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge

A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate Cancer